Physician profile
Luis C Jorge
NPI 1659342970
$1,278.44
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,102 · 2020: $176.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.11 | 2019-2020 | |
| Pfizer INC. | $163.57 | 2019 | |
| Amgen INC. | $135.40 | 2019-2020 | |
| Glaxosmithkline, LLC. | $131.87 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $123.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $71.13 | 2019 | |
| Orexo US, INC. | $65.51 | 2019 | |
| Novo Nordisk INC | $61.45 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $56.07 | 2019 | |
| Lilly USA, LLC | $53.37 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.64 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $40.97 | 2019-2020 | |
| Astellas Pharma US INC | $35.73 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $27.77 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.69 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24.89 | 2019 | |
| Merck Sharp & Dohme LLC | $22.26 | 2019 | |
| Biodelivery Sciences International, INC. | $13.26 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Jorge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.